Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update indicating completion of a cancer vaccine therapy study in patients with metastatic cancer, including melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED